Home › Cases › Myocarditis Presenting as Heart Failure
Pericarditis & Myocarditis
Myocarditis Presenting as Heart Failure
6 questions
Question 1 · A young patient with heart failure
Correct answer: Acute myocarditis causing new heart failure
Why
A young patient with no coronary risk factors, a viral prodrome, a high troponin and new heart failure is the classic myocarditis presentation. Raised troponin shows myocardial injury; even unobstructed coronaries do not prove myocarditis. Seek urgent cardiology assessment, exclude ACS and use CMR to characterise inflammation.
Key point
Young + viral prodrome + high troponin + new heart failure = myocarditis until proven otherwise.
Question 2 · Investigations
Correct answer: ECG, echo, CXR, inflammatory markers — and discuss with cardiology, as CMR is the non-invasive standard for confirming myocarditis
Why
Initial work-up is ECG, echo (looking at LV function and wall motion), CXR and inflammatory markers, with cardiology involvement. Cardiac MRI is the non-invasive standard for confirming myocardial inflammation. Endomyocardial biopsy is reserved for specific situations such as suspected giant cell or fulminant myocarditis, not routine first-line use.
Key point
Echo and ECG first; CMR confirms. Biopsy is for selected cases only.
Question 3 · Where to nurse her
Correct answer: A monitored bed with cardiology input — myocarditis carries a risk of arrhythmia and rapid deterioration
Why
Acute myocarditis with impaired LV function needs a monitored bed: the risks are ventricular arrhythmia, complete heart block and progression to fulminant myocarditis with cardiogenic shock, and deterioration can be rapid. A blood pressure of 96/62 with an EF of 32% is not stability, it is compensation.
Key point
Impaired LV function in myocarditis means a monitored bed — arrhythmia and rapid decline are the risks.
Question 4 · Treatment
Correct answer: Supportive heart failure management, with treatment of any specific identified cause — there is no routine antiviral or immunosuppressive therapy
Why
Management is supportive: standard heart failure therapy, rhythm monitoring, and treatment of a specific cause if one is found. There is no routine antiviral or immunosuppressive treatment for viral myocarditis, and immunosuppression is reserved for selected causes under specialist care, usually guided by biopsy; urgent suspected giant-cell or immune-checkpoint-inhibitor myocarditis may need treatment before confirmation. High-dose NSAIDs are not the treatment for myocarditis.
Key point
Supportive heart failure care. No routine steroids or antivirals in viral myocarditis.
Question 5 · Deterioration
Correct answer: Fulminant myocarditis with cardiogenic shock — urgent critical care and cardiology, discuss with a centre offering mechanical support
Why
This is fulminant myocarditis with cardiogenic shock. It needs urgent critical care and early discussion with a centre able to offer mechanical circulatory support, since these patients can recover well if supported through the acute phase. Escalating diuretics in shock worsens perfusion, and beta-blockade in cardiogenic shock is dangerous.
Key point
Shock in myocarditis is fulminant disease — escalate early; outcomes with support can be good.
Question 6 · Follow-up
Correct answer: Exercise restriction with cardiology follow-up and repeat imaging before returning to sport
Why
Exercise restriction with structured cardiology follow-up is essential — exertion during active inflammation is linked to arrhythmia and sudden death, and LV function needs reassessment before return to sport. Recovery is common but not universal: a proportion develop dilated cardiomyopathy. Lifelong inactivity is neither necessary nor advised.
Key point
Restrict exercise, follow up, re-image before return to sport. Some progress to cardiomyopathy.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.